2 results match your criteria: "TAHA Clinical Trial Group Shiraz University of Medical Sciences Shiraz Iran.[Affiliation]"
Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study.
Health Sci Rep
July 2024
Health Human Resources Research Center, School of Management and Medical Information Sciences Shiraz University of Medical Sciences Shiraz Iran.
Background And Aims: Cardiovascular diseases (CVDs) are one of the major diseases in developing and developed countries and have high prevalence and mortality rates. Pharmacological interventions, especially the use of combination medications, can have preventive effects in patients with CVDs. Recently, in the PolyIran trial, a combination of atorvastatin, hydrochlorothiazide, aspirin, and valsartan or enalapril (Polypill) was shown to be effective in providing survival benefits as a primary prevention strategy.
View Article and Find Full Text PDFEffect of different reperfusion strategies on recovery of ventricular function after ST-segment elevation myocardial infarction: A longitudinal single-center study.
Health Sci Rep
June 2024
Department of Cardiovascular Medicine, TAHA Clinical Trial Group Shiraz University of Medical Sciences Shiraz Iran.
Background And Aims: Although the clinical benefit of percutaneous coronary intervention (PCI) on cardiovascular outcomes has been widely investigated, the impact of this revascularization strategy compared to other alternatives on the degree of left ventricular function recovery is poorly demonstrated. In this regard, we investigated whether time delays between the presentation of ST-segment elevation myocardial infarction (STEMI) and PCI in reperfusion strategies have different impacts on left ventricular function recovery.
Methods: In this single-center study, all the patients who presented with STEMI and a reduced left ventricular ejection fraction (LVEF ≤ 40%) were enrolled.